Drug Development

The first generic Reductil on the market

Published in Medical Letter on the CDC and FDA, July 22nd, 2007

Han Mi said Slimmer, a generic version of Abbott's Reductil, is likely to be cleared by Korean Food and Drug Administration as early as July 2, making Slimmer the first generic Reductil in South Korea.

Slimmer, known generically as sibutramine mesilate, is an improved version drug which is developed domestically. Han Mi had invested 4.2 billion won in the development of Slimmer for five years with financial supports from the Ministry of Commerce, Industry and Energy.

Slimmer went through preclinical, phase I, phase III trials and toxicity studies almost like a new drug. Han Mi said "Only preclinical and phase I trials are required for an improved...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2007-07-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry